logo
  • Home
  • Team
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
  • News
  • Careers
  • Investors

News

Press releases and other Rewind Therapeutics news

September 2, 2020

Rewind Therapeutics appoints Biopharmaceutical Industry Veteran Kees Been as Non-Executive Director


0 Comments4 Minutes

August 1, 2019

Rewind Therapeutics krijgt VLAIO-subsidie van 2,9 miljoen euro voor het ontdekken en ontwikkelen van nieuwe kandidaat-geneesmiddelen voor myeline-gerelateerde neurologische aandoeningen


0 Comments8 Minutes

August 1, 2019

Rewind Therapeutics awarded €2.9 million VLAIO grant to discover and develop novel drug candidates


0 Comments8 Minutes

February 6, 2019

Rewind Therapeutics expands Scientific Advisory Board with addition of Professors Robin Franklin and Catherine Lubetzki, bringing further expertise in myelin and multiple sclerosis research


0 Comments5 Minutes

October 10, 2018

Rewind Therapeutics Builds Scientific Advisory Board to Accelerate Its Development of New Therapies for Myelin-Related Diseases


0 Comments4 Minutes

October 3, 2018

Rewind Therapeutics Appoints Leading Neuroscience Drug Developer Ian J. Reynolds as Chief Executive Officer


0 Comments3 Minutes

January 4, 2018

Belgian Biotech Hits ‘Fast Forward’ on Multiple Sclerosis Therapies


0 Comments2 Minutes

January 4, 2018

Rewind Therapeutics Secures 15.2 M EURO to Develop Novel Remyelination Therapies


1 Comment6 Minutes

Working with

Boehringer Ingelheim Logo
Merck Ventures logo
Axxam logo
KU Leuven logo
PMV logo

© 2021 Rewind Therapeutics. All rights reserved. Site by Alex.

Privacy Policy

We use cookies to ensure we give you the best experience on our website. If you continue to use this site, we will assume you are happy with it.Continue